Menu
BioCentury This Week
Podcast image
Ep. 358 - Europe's biotech challenge
23 mins; April 01, 2026
Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision
28 mins; March 30, 2026
Ep. 356 - Arrowhead’s arc. Plus: AI in biotech venture, Synnovation, MFN
33 mins; March 23, 2026
Ep. 355 - Capital market mood, Xenon data, Friedreich ataxia pipeline
24 mins; March 16, 2026
Ep. 354 - East-West Summit Takeaways
26 mins; March 13, 2026
Ep. 353 - Prasad Departure and Future of Fibrosis Therapies
37 mins; March 09, 2026
Ep. 352 - A Multipolar Biopharma World; Rare Disease Spotlight
34 mins; March 02, 2026
Ep. 351 - Gilead's Arcellx Buy. Plus: ctDNA as Surrogate Endpoint
35 mins; February 23, 2026
Ep. 350 - Oral SERD Spotlight. Plus: Setbacks at FDA
26 mins; February 17, 2026
Ep. 349 - Start-up Spotlight, Compounding Wegovy & Neuropysch
33 mins; February 09, 2026
Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules
31 mins; February 02, 2026
Ep. 347 - Speeding China's Innovation. Plus: Neuro Catalysts and Newcos
29 mins; January 26, 2026
Ep. 346 - 2026 Public Markets Preview
30 mins; January 22, 2026
Ep. 345 - TAC to the Future. Plus: GSK Deal, MFN
30 mins; January 20, 2026
Ep. 344 - JPM Momentum and Asia’s Hotbeds of Innovation
43 mins; January 15, 2026
Ep. 343 - JPM Deals, Policy Outlook, Approval Trends
25 mins; January 12, 2026
Ep. 342 - 2026 Biotech Kickoff
25 mins; January 05, 2026
Ep. 341 - BioCentury's '25-'26 Picks. Plus: BioMarin & Biotech ICYMI
38 mins; December 29, 2025
Ep. 340 - Obesity Data, Kymera & FDA Survey Results
32 mins; December 15, 2025
Ep. 339 - Biotech M&A, In Vivo CAR Ts & FDA Tumult
35 mins; December 08, 2025
Ep. 338 - Semaglutide’s Alzheimer’s Miss. Plus: Vaccine Policy, Cell, Gene Therapy Funding
29 mins; December 01, 2025
Ep. 337 - FDA’s Moving Goalposts & China’s Innovation Arc
33 mins; November 24, 2025
Ep. 336 - Cautious Optimism and M&A Momentum
41 mins; November 21, 2025
Ep. 335 - Neurology's Coming Inflection Point
40 mins; November 20, 2025
Ep. 334 - Pazdur’s New FDA Role, SITC & China RNAi
36 mins; November 17, 2025
Ep. 333 - Is This Korea’s Biotech Moment?
45 mins; November 12, 2025
Ep. 332 - Obesity in Focus. Plus: What’s Next for FDA
28 mins; November 10, 2025
Ep. 331 - Metsera M&A Melee & Tidmarsh Ouster
27 mins; November 03, 2025
Ep. 330 - China's Innovation Moment
43 mins; October 31, 2025
Ep. 329 - Novartis' $12B Avidity Buy. Plus: Base Editors
31 mins; October 27, 2025
Ep. 328 - Brain Shuttles, GSK Q&A and FDA Vouchers
33 mins; October 20, 2025
Ep. 327 - Where Gene & Cell Therapy Go Next With Evotec's Bernd MĂĽhlenweg
23 mins; October 15, 2025
Ep. 326 - Market Outlook, Biosecure Returns, Biotech M&A
36 mins; October 13, 2025
Ep. 325 - Pfizer MFN Deal, New Trial Paradigm & Billion $ Fund
30 mins; October 06, 2025
Ep. 324 - Genmab, GSK and Drug Pricing
28 mins; September 29, 2025
Ep. 323 - Agentic AI: From New Targets to the Clinic
29 mins; September 24, 2025
Ep. 322 - Takeaways from BioCentury Grand Rounds Europe
30 mins; September 23, 2025
Ep. 321 - Pfizer’s Obesity Play & U.K. in Focus
48 mins; September 22, 2025
Ep. 320 - U.K. Biotech, U.S.-China, Insmed
29 mins; September 15, 2025
Ep. 319 - David Baltimore’s Legacy, Atlas Fund, MASH Pipeline and more
28 mins; September 08, 2025
Ep. 318 - Newco Takes on CV Risk. Plus: Disrupting Vaccines
32 mins; September 02, 2025
Ep. 317 - Biotech IPOs, FDA-Stealth & Patent Threat
24 mins; August 25, 2025
Ep. 316 - Trends in Pharma Deals
29 mins; August 18, 2025
Ep. 315 - China Speed: Data, Deals, First in Class
33 mins; August 13, 2025
Ep. 314 - Prasad, Lilly Obesity, Acadia & Biosecure
39 mins; August 11, 2025
Ep. 313 - Lessons from FDA's Prasad. Plus: What's next for Novo, Bayer
33 mins; August 04, 2025
Ep. 312 - Biotech Progress Report
29 mins; July 29, 2025
Ep. 311 - The Asia Deals Landscape, U.K. Biotech & More
42 mins; July 28, 2025
Ep. 310 - Sarepta & What's Next for Gene Therapy. Plus: Leading FDA's CDER
31 mins; July 21, 2025
Ep. 309 - 3Q Markets Preview; Quantum Computing; Makary’s First 100 Days
37 mins; July 14, 2025
Ep. 308 - Grand Rounds - Europe Preview
31 mins; July 09, 2025
Ep. 307 - How Cancer Regulation is — and isn’t — Changing at FDA
29 mins; July 08, 2025
Ep. 306 - Treg Inflection Point; Biotech's Next Big Story; Tax Bill Consequences
31 mins; July 07, 2025
Ep. 305 - FDA's Future; In Vivo CAR T Plays; Psychedelics; CDK2
38 mins; June 30, 2025
Ep. 304 - Syncona Reshapes Fund; Lilly's $1B Verve Bet; FDA's 2-Track Future
35 mins; June 23, 2025
Ep. 303 - Gene Therapy Safety, Amylin in Obesity & FDA's Future
33 mins; June 16, 2025
Ep. 302 - Takeaways from BioCentury Grand Rounds Chicago
31 mins; June 11, 2025
Ep. 301 - ASCO’s First-in-Human Trials, Crossover Investors & FDA's Rare Disease Plans
35 mins; June 09, 2025
Ep. 300 - Biotech’s $13B Deal Day, ASCO's Hot Targets, Drug Pricing Threat
38 mins; June 02, 2025
Ep. 299 - ASCO, EpCAM, Rocket & HK IPOs
30 mins; May 27, 2025
Ep. 298 - Takeaways from the 25th Bio€quity Europe
38 mins; May 22, 2025
Ep. 297 - European Biotech's Moment? Plus: Biomarin, Boston Deals & Novo Nordisk CEO
35 mins; May 19, 2025
Ep. 296 - Trends in Obesity, Vinay Prasad at FDA, Ovarian Cancer Insights
33 mins; May 12, 2025
Ep. 295 - Bio€quity Europe 2025 Preview
28 mins; May 08, 2025
Ep. 294 - AACR Spotlight on SMARCA2 degraders. Plus: David Baker, Drug Pricing
30 mins; May 05, 2025
Ep. 293 - Tau Time for Alzheimer's. Plus: FDA Delays, Merck's $4B Deal, HK IPOs
31 mins; April 28, 2025
Ep. 292 - Myasthenia Gravis Spotlight & AACR Preview
25 mins; April 25, 2025
Ep. 291 - Grand Rounds - U.S. Preview
31 mins; April 24, 2025
Ep. 290 - Biotech Survey Sees Tough Days Ahead. Plus: FDA, China Speed
38 mins; April 21, 2025
Ep. 289 - Replacing Animal Models. Plus: RFK Jr. & FDA
36 mins; April 14, 2025
Ep. 288 - FDA and Tariffs Turmoil, and AACR Preview
26 mins; April 07, 2025
Ep. 287 - The Bear is Back: Marks’ Ouster, Tariffs and a Tumbling XBI
25 mins; March 31, 2025
Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
24 mins; March 24, 2025
Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play
28 mins; March 17, 2025
Ep. 284 - Takeaways from the East-West Summit
41 mins; March 11, 2025
Ep. 283 - Makary’s FDA Agenda, Amylin in Obesity and Life After DEI
31 mins; March 10, 2025
Ep. 282 - CRISPR Lessons: Plus, AbbVie Enters Obesity
23 mins; March 03, 2025
Ep. 281 - Roche Reboot and 5 Things on Trump 2.0
22 mins; February 24, 2025
Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs
27 mins; February 18, 2025
Ep. 279 - East-West Summit Preview
29 mins; February 14, 2025
Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine
26 mins; February 10, 2025
Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug
25 mins; February 03, 2025
Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler
21 mins; January 31, 2025
Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH
33 mins; January 27, 2025
Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI
36 mins; January 21, 2025
Ep. 273 - JPM 2025 Wrap: Sunny Skies & Megarounds
22 mins; January 16, 2025
Ep. 272 - JPM Deal Buzz & Rep. Auchincloss’ Take on Biopharma
27 mins; January 13, 2025
Ep. 271 - Biotech in the New Year. Plus: Beyond Biosecure
34 mins; January 06, 2025
Ep. 270 - Temple’s FDA Legacy. Plus: Chinese Innovation & Novo Obesity Data
34 mins; December 30, 2024
Bonus Content - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
34 mins; December 23, 2024
Ep. 269 - Trends in VC Funds, Obesity Start-ups and More
33 mins; December 16, 2024
Ep. 268 - Biosecure Setback & Novartis' $1B PTC Deal
21 mins; December 09, 2024
Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
27 mins; December 02, 2024
Ep. 266 - Jefferies Recap, FDA Commissioner & Biosecure Update
26 mins; November 25, 2024
Ep. 265 - RFK Jr. & HHS, Blenrep's Comeback, China Deals
29 mins; November 18, 2024
Ep. 264 - Prepping for Trump & Alzheimer's Ethics
29 mins; November 11, 2024
Ep. 263 - Alzheimer Insights: Anti-Amyloid Safety & Tau Teaser
34 mins; November 04, 2024
Ep. 262 - EGFR Case Study, FDA & Politics
23 mins; October 28, 2024
Ep. 261 - China Summit: Reinventing Your China Strategy
31 mins; October 23, 2024
Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
31 mins; October 21, 2024
Click here to see more
Useful pages

Apply to teach

Reviews

Help & FAQs

Blog

Spanish Podcast

French Podcast

Italian Podcast

About Us

Contact Us

Terms & Privacy

Find a tutor

Arabic tutors

Chinese tutors

Dutch tutors

English tutors

French tutors

German tutors

Greek tutors

Italian tutors

Japanese tutors

Korean tutors

Portuguese tutors

Romanian tutors

Russian tutors

Spanish tutors

Swedish tutors

Thai tutors

More languages soon!

Languages

Learn Arabic

Learn Chinese

Learn Dutch

Learn English

Learn French

Learn German

Learn Greek

Learn Italian

Learn Japanese

Learn Korean

Learn Portuguese

Learn Romanian

Learn Russian

Learn Spanish

Learn Swedish

Learn Thai

© 2026 LanguaTalk, All Rights Reserved